NeoModulus Earns Dual Honors with 'Enterprise Technology Center' Designation and Expert Recognition, Files IPO Prospectus

Dec 20, 2024 09:00 CST Updated 09:00

Neo Modulus

Developer of Human Tissue Repair and Organ Regeneration Products

Technology and talent are the core drivers of Neo Modulus' development.Neo Modulus continuously invests in research and development to ensure that technological innovation can drive the company's growth and competitiveness. At the same time, Neo Modulus is committed to creating an environment that attracts and retains top talent, ensuring that every partner can grow with the company and achieve a win-win situation for personal value and corporate goals.

Recently, the Suzhou Municipal Industry and Information Technology Bureau announced the proposed list of enterprises for the 28th batch of municipal-level enterprise technology centers in Suzhou.Neo Modulus (Suzhou) Medical Sci-Tech Co., Ltd. Makes the List, Officially Awarded "Enterprise Technology Center"。

At the same time, the Organization Department of the Weifang Municipal Committee of the Communist Party of China and the Weifang Human Resources and Social Security Bureau announced the list of experts with outstanding contributions in Weifang for the year 2024.Guo Gang, General Manager of Neo Modulus (Shandong) Medical Sci-Tech Co., Ltd., Successfully Selected。

Double Honors at Year-End: The Greatest Affirmation of Neo Modulus' "Technology + Talent" Dual-Drive StrategyNeo Modulus will take this as an opportunity to continue adhering to the development philosophy of "innovation and internationalization," increase R&D investment, continuously enhance the innovation capability of the corporate technology center, improve the talent cultivation and development mechanism, and shoulder the responsibility of a national enterprise. It aims to provide innovative and high-quality medical solutions, contribute more to the advancement and development of the high-end medical device industry, and benefit patients worldwide.

Statement:

This article is for news purposes only, and its content is solely intended for information dissemination or industry exchange.Nothing herein shall be construed as advertising or representing any express or implied advertising, nor shall it be deemed to contain any purpose of sale or promise of sale.For accurate information, please consult a professional medical institution for expert advice.

If any individual or media, website wants to reprint this article, please contact the official account for authorization and indicate the source of the reprint.